Medicare Enrolled

Dr. Syed Asif Rizvi, MD

Endocrinology · Apex, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1001 W WILLIAMS ST, Apex, NC 27502
9193637576
In practice since 2007 (19 years)
NPI: 1972639003 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rizvi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rizvi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rizvi

Dr. Syed Asif Rizvi is an endocrinology specialist in Apex, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rizvi performed 1,763 Medicare services across 893 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rizvi received a total of $4,143 from 35 pharmaceutical and/or device companies across 221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rizvi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 34% volume in NC $4,143 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,763
Medicare services
Top 34% in NC for endocrinology
893
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~93 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,028 $83 $167
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
305 $123 $223
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
182 $74 $322
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
89 $25 $100
Ultrasound of arm and leg arteries
This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries.
55 $60 $350
Autonomic nervous system function test
This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure.
55 $92 $250
New patient office visit, complex (60-74 min) 49 $134 $330
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,143
Total received (2018-2024)
Avg $592/year across 7 years
Top 38% in NC for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
221
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,131 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$274
2023
$384
2022
$380
2021
$202
2020
$92
2019
$1,855
2018
$956

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$84
SANOFI-AVENTIS U.S. LLC
$44
Lilly USA, LLC
$29
AIMMUNE THERAPEUTICS, INC.
$27
ABBVIE INC.
$18
Corcept Therapeutics
$17
Novo Nordisk Inc
$14
Abbott Laboratories
$14
CeQur Corporation
$13
Medtronic, Inc.
$13
Top 3 companies account for 57.5% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic MiniMed, Inc.
$1,070
Boehringer Ingelheim Pharmaceuticals, Inc.
$474
Novo Nordisk Inc
$412
AstraZeneca Pharmaceuticals LP
$322
IBSA Pharma Inc.
$290
Lilly USA, LLC
$187
AbbVie, Inc.
$166
Shire North American Group Inc
$158
SANOFI-AVENTIS U.S. LLC
$146
Radius Health, Inc.
$144
Amgen Inc.
$137
Janssen Pharmaceuticals, Inc
$134
Medtronic, Inc.
$50
Antares Pharma, Inc.
$48
Merck Sharp & Dohme Corporation
$41
Amarin Pharma Inc.
$36
Senseonics, Incorporated
$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$31
AIMMUNE THERAPEUTICS, INC.
$27
Valeritas, Inc.
$19
ABBVIE INC.
$18
Aegerion Pharmaceuticals, Inc.
$17
Corcept Therapeutics
$17
Ascendis Pharma Inc
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Amneal Pharmaceuticals LLC
$15
Novartis Pharmaceuticals Corporation
$15
Regeneron Healthcare Solutions, Inc.
$15
Abbott Laboratories
$14
Allergan Inc.
$14
Kyowa Kirin, Inc.
$13
CeQur Corporation
$13
Mannkind Corporation
$12
Eisai Inc.
$12
Ultragenyx Pharmaceutical Inc.
$12
Top 3 companies account for 47.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BYDUREON · Belviq · CYCLOSET · CeQur Simplicity · Crysvita · EVENITY · Eversense · FARXIGA · HUMATROPE · HUMULIN · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · MINIMED 770G · MINIMED 780G · MYALEPT · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · Ozempic · PRALUENT ALIROCUMAB INJECTION · PROCLAIM · Repatha · STEGLATRO · SYNJARDY · SYNTHROID · Synthroid · TOUJEO · TRULICITY · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Apex?
Compare endocrinologists in the Apex area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
48
Per 100K population
4.2
County median income
$101,763
Nearest hospital
WAKEMED, CARY HOSPITAL
7.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rizvi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rizvi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rizvi performed 1,028 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rizvi receive payments from pharmaceutical companies?
Yes. Dr. Rizvi received a total of $4,143 from 35 companies across 221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rizvi's costs compare to other endocrinologists in Apex?
Dr. Rizvi's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rizvi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →